|
CN1124927A
(zh)
|
1993-03-29 |
1996-06-19 |
辛辛那提大学 |
Yy肽类似物及其应用
|
|
US5574010A
(en)
|
1994-11-14 |
1996-11-12 |
The Regents Of The University Of California |
Treatment of pancreatic tumors with peptide YY and analogs thereof
|
|
WO1998020885A1
(en)
|
1996-11-13 |
1998-05-22 |
University Of Cincinnati |
Analogs of peptide yy and uses thereof
|
|
EP0908515A3
(en)
|
1997-09-16 |
2000-04-26 |
Smithkline Beecham Plc |
Pancreatic polypeptide
|
|
US6046167A
(en)
|
1998-03-25 |
2000-04-04 |
University Of Cincinnati |
Peptide YY analogs
|
|
ATE232200T1
(de)
|
1998-06-08 |
2003-02-15 |
Schering Corp |
Neuropeptid y5-rezeptorantagonisten
|
|
US7601691B2
(en)
|
1999-05-17 |
2009-10-13 |
Conjuchem Biotechnologies Inc. |
Anti-obesity agents
|
|
EP2123293A3
(en)
|
2000-12-14 |
2010-09-08 |
Amylin Pharmaceuticals, Inc. |
Peptide YY and petide YY agonists for treatment of metabolic disorders
|
|
US6589938B2
(en)
|
2001-06-29 |
2003-07-08 |
National University Of Singapore |
Use of angiotensin I derivatives as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders
|
|
ES2320979T3
(es)
|
2001-09-24 |
2009-06-01 |
Imperial Innovations Limited |
Pyy-36 para la reduccion o prevencion de la obesidad.
|
|
US8058233B2
(en)
|
2002-01-10 |
2011-11-15 |
Oregon Health And Science University |
Modification of feeding behavior using PYY and GLP-1
|
|
US7811989B2
(en)
|
2003-01-17 |
2010-10-12 |
Ipsen Pharma S.A.S. |
Peptide YY analogs
|
|
US7572581B2
(en)
|
2003-06-30 |
2009-08-11 |
Roche Molecular Systems, Inc. |
2′-terminator nucleotide-related methods and systems
|
|
TW200522976A
(en)
|
2003-09-19 |
2005-07-16 |
Novo Nordisk As |
Novel plasma protein affinity tags
|
|
CN100444898C
(zh)
|
2003-09-19 |
2008-12-24 |
诺沃挪第克公司 |
治疗肽的清蛋白结合型衍生物
|
|
EP1670515A2
(en)
|
2003-09-19 |
2006-06-21 |
Novo Nordisk A/S |
Albumin-binding derivatives of therapeutic peptides
|
|
CN101665538A
(zh)
|
2003-12-18 |
2010-03-10 |
诺沃挪第克公司 |
与白蛋白样物质相连的新glp-1类似物
|
|
KR20140011431A
(ko)
|
2004-02-11 |
2014-01-28 |
아밀린 파마슈티칼스, 엘엘씨. |
선택가능한 특성을 갖는 하이브리드 폴리펩티드
|
|
EP1789440A4
(en)
|
2004-02-11 |
2008-03-12 |
Amylin Pharmaceuticals Inc |
REASONS FOR THE FAMILY OF PANCREATIC POLYPEPTIDES AND POLYPEPTIDES CONTAINING THEM
|
|
EP2272524A3
(en)
|
2004-03-17 |
2011-02-02 |
7TM Pharma A/S |
Y2 selective receptor agonists for therapeutic interventions
|
|
DK2060266T3
(da)
|
2004-03-17 |
2011-11-14 |
7Tm Pharma As |
Y4-selektiv receptoragonist PP2-36 til terapeutiske indgreb
|
|
WO2005089790A2
(en)
|
2004-03-17 |
2005-09-29 |
7Tm Pharma A/S |
Y2/y4 selective receptor agonists for therapeutic interventions
|
|
CN1933848A
(zh)
|
2004-03-17 |
2007-03-21 |
7Tm制药联合股份有限公司 |
用于治疗性干预的y2选择性受体激动剂
|
|
GB0412181D0
(en)
|
2004-06-01 |
2004-06-30 |
Celltech R&D Ltd |
Biological products
|
|
ES2542228T3
(es)
|
2004-07-08 |
2015-08-03 |
Novo Nordisk A/S |
Marcas de prolongación polipeptídica que comprenden un resto de tetrazol
|
|
WO2006020207A2
(en)
|
2004-07-19 |
2006-02-23 |
University Of Cincinnati |
Compounds for control of appetite
|
|
WO2006049681A2
(en)
|
2004-08-30 |
2006-05-11 |
Bayer Pharmaceuticals Corporation |
Selective neuropeptide y2 receptor agonists
|
|
US7410949B2
(en)
|
2005-01-18 |
2008-08-12 |
Hoffmann-La Roche Inc. |
Neuropeptide-2 receptor (Y-2R) agonists and uses thereof
|
|
GB0504857D0
(en)
|
2005-03-09 |
2005-04-13 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
|
WO2007008778A2
(en)
|
2005-07-11 |
2007-01-18 |
Nastech Pharmaceutical Company Inc. |
Formulations for enhanced mucosal delivery of pyy
|
|
CN101222942A
(zh)
|
2005-07-18 |
2008-07-16 |
诺沃-诺迪斯克有限公司 |
用于治疗肥胖的肽
|
|
CN101268099A
(zh)
*
|
2005-09-21 |
2008-09-17 |
7Tm制药联合股份有限公司 |
用于治疗性干预的y4选择性受体激动剂
|
|
EP1934245B1
(en)
|
2005-09-21 |
2011-07-13 |
7TM Pharma A/S |
Y2 selective receptor agonists for therapeutic interventions
|
|
EP1962959B1
(en)
|
2005-12-07 |
2012-03-14 |
F. Hoffmann-La Roche AG |
Neuropeptide-2 receptor-agonists
|
|
WO2007068718A1
(en)
|
2005-12-14 |
2007-06-21 |
Novo Nordisk A/S |
Polypeptide protracting tags
|
|
US20070197445A1
(en)
|
2006-01-18 |
2007-08-23 |
University Of Cincinnati |
Compounds for control of appetite
|
|
AU2007227202B2
(en)
|
2006-03-21 |
2013-08-22 |
Amylin Pharmaceuticals, Llc |
Peptide-peptidase inhibitor conjugates and methods of using same
|
|
GB0613196D0
(en)
|
2006-07-03 |
2006-08-09 |
Imp Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
|
GB0621973D0
(en)
|
2006-11-03 |
2006-12-13 |
Philogen Spa |
Binding molecules and uses thereof
|
|
US20090099074A1
(en)
|
2007-01-10 |
2009-04-16 |
Conjuchem Biotechnologies Inc. |
Modulating food intake
|
|
US20100022446A1
(en)
|
2007-01-18 |
2010-01-28 |
Novo Nordisk A/S |
Use of Peptides in Combination with Surgical Intervention for the Treatment of Obesity
|
|
US20100016237A1
(en)
|
2007-01-18 |
2010-01-21 |
Novo Nordisk A/S |
Novel Peptides for Use in the Treatment of Obesity
|
|
GB0708226D0
(en)
|
2007-04-27 |
2007-06-06 |
7Tm Pharma As |
Y-receptor agonists
|
|
BRPI0814629A2
(pt)
|
2007-07-09 |
2015-01-27 |
Imp Innovations Ltd |
Compostos e seus efeitos sobre o comportamento alimentar
|
|
US20100261637A1
(en)
|
2007-09-05 |
2010-10-14 |
Novo Nordisk A/S |
Peptides derivatized with a-b-c-d- and their therapeutical use
|
|
US20100286029A1
(en)
|
2007-09-11 |
2010-11-11 |
Dorian Bevec |
Use of a peptide as a therapeutic agent
|
|
US8598314B2
(en)
|
2007-09-27 |
2013-12-03 |
Amylin Pharmaceuticals, Llc |
Peptide-peptidase-inhibitor conjugates and methods of making and using same
|
|
RU2504550C2
(ru)
*
|
2008-05-16 |
2014-01-20 |
Ново Нордиск А/С |
Длительно действующие агонисты рецепторов y2 и(или) y4
|
|
US8299023B2
(en)
|
2008-09-17 |
2012-10-30 |
Hoffmann-La Roche Inc. |
Neuropeptide-2 receptor (Y-2R) agonists
|
|
GB0817067D0
(en)
|
2008-09-18 |
2008-10-22 |
7Tm Pharma As |
Intestinal treatment
|
|
BRPI0921230A2
(pt)
|
2008-11-05 |
2018-10-30 |
Hoffmann La Roche |
agonistas de receptor de neuropeptídeos-2 (y-2r) e usos dos mesmo.
|
|
MX2011008774A
(es)
|
2009-02-20 |
2011-10-24 |
Ipsen Pharma Sas |
Conjugados citotoxicos que tienen un compuesto de unión de receptores de neuropeptidos y.
|
|
CN102573888A
(zh)
*
|
2009-09-18 |
2012-07-11 |
诺和诺德公司 |
长效y2 受体激动剂
|
|
JP2013507414A
(ja)
|
2009-10-13 |
2013-03-04 |
エフ．ホフマン−ラ ロシュ アーゲー |
神経ペプチド−２受容体（ｙ−２ｒ）アゴニスト
|
|
EP2498800A1
(en)
|
2009-11-13 |
2012-09-19 |
Novo Nordisk A/S |
Long-acting y2 receptor agonists
|
|
WO2011131646A1
(en)
|
2010-04-20 |
2011-10-27 |
Novo Nordisk A/S |
Long-acting gastrin derivatives
|
|
MX341025B
(es)
|
2010-05-05 |
2016-08-04 |
Boehringer Ingelheim Int Gmbh * |
Terapia de combinacion.
|
|
GB201101459D0
(en)
|
2011-01-27 |
2011-03-16 |
Imp Innovations Ltd |
Novel compounds and thier effects on fedding behaviour
|
|
EP2855517A1
(en)
|
2012-05-29 |
2015-04-08 |
Novo Nordisk A/S |
Pancreatic polypeptide compounds and use
|
|
EP2992008B1
(en)
|
2013-05-02 |
2019-04-10 |
GlaxoSmithKline Intellectual Property Development Limited |
Therapeutic peptides
|
|
WO2015071355A1
(en)
|
2013-11-15 |
2015-05-21 |
Novo Nordisk A/S |
Selective pyy compounds and uses thereof
|
|
MX392572B
(es)
|
2015-06-12 |
2025-03-24 |
Novo Nordisk As |
Compuestos del péptido yy (pyy) selectivos y sus usos.
|